"Antibodies, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulins produced in response to VIRAL ANTIGENS.
| Descriptor ID |
D000914
|
| MeSH Number(s) |
D12.776.124.486.485.114.254 D12.776.124.790.651.114.254 D12.776.377.715.548.114.254
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Viral".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Viral".
This graph shows the total number of publications written about "Antibodies, Viral" by people in this website by year, and whether "Antibodies, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 5 | 1 | 6 |
| 1996 | 6 | 8 | 14 |
| 1997 | 2 | 5 | 7 |
| 1998 | 3 | 9 | 12 |
| 1999 | 5 | 7 | 12 |
| 2000 | 2 | 6 | 8 |
| 2001 | 5 | 7 | 12 |
| 2002 | 5 | 14 | 19 |
| 2003 | 6 | 9 | 15 |
| 2004 | 3 | 9 | 12 |
| 2005 | 6 | 11 | 17 |
| 2006 | 5 | 3 | 8 |
| 2007 | 1 | 6 | 7 |
| 2008 | 6 | 12 | 18 |
| 2009 | 5 | 9 | 14 |
| 2010 | 2 | 7 | 9 |
| 2011 | 6 | 13 | 19 |
| 2012 | 10 | 12 | 22 |
| 2013 | 14 | 7 | 21 |
| 2014 | 13 | 12 | 25 |
| 2015 | 21 | 11 | 32 |
| 2016 | 13 | 17 | 30 |
| 2017 | 13 | 15 | 28 |
| 2018 | 19 | 14 | 33 |
| 2019 | 13 | 12 | 25 |
| 2020 | 23 | 19 | 42 |
| 2021 | 28 | 33 | 61 |
| 2022 | 7 | 59 | 66 |
| 2023 | 5 | 47 | 52 |
| 2024 | 29 | 12 | 41 |
| 2025 | 17 | 11 | 28 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibodies, Viral" by people in Profiles.
-
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenstr?m macroglobulinemia. Blood Adv. 2025 Sep 23; 9(18):4568-4579.
-
Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations. Sci Adv. 2025 Sep 12; 11(37):eadx3505.
-
Structural elucidation of a unique binding mode by an intact alphavirus human IgG molecule to a quaternary epitope. Nat Commun. 2025 Aug 19; 16(1):7716.
-
Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine. Cell Rep. 2025 Aug 26; 44(8):116098.
-
Household clusters of SARS-CoV-2 Omicron subvariants contemporaneously sequenced from dogs and their owners. mSphere. 2025 Jul 29; 10(7):e0007425.
-
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses. Nat Commun. 2025 Jul 01; 16(1):5702.
-
Infant Antibodies After Maternal COVID-19 Vaccination During Pregnancy or Postpartum. Pediatrics. 2025 Jul 01; 156(1).
-
Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel. Vaccine. 2025 Aug 13; 61:127361.
-
Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment. PLoS One. 2025; 20(6):e0325561.
-
Pan-H7 influenza human antibody virus neutralization depends on avidity and steric hindrance. JCI Insight. 2025 Jul 08; 10(13).